Celdara Medical, LLC Receives $2.1M SBIR Award from the National Heart, Lung, and Blood Institute

Celdara Medical, LLC announced today that it has received a $2.1M SBIR Phase II award from the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI). This award will support the preclinical development of Celdara Medical’s dendritic cell targeted therapy for myocardial infarction-induced ischemia-reperfusion injury. “Myocardial infarction is […]

Continue Reading

Enquire now

Give us a call or fill in the form below and we'll contact you. We endeavor to answer all inquiries within 24 hours on business days.